Filgrastim clinical trials
Also written Neupogen, r-metHuG-CSF, rG-CSF and Granix.
How each study uses Filgrastim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Filgrastim studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Feb 1991 · NEUPOGEN · BLA 103353 (FDA, Drugs@FDA)
- European Union
- 15 Sept 2008 · Filgrastim ratiopharm · EMEA/H/C/000824 (EMA; a biosimilar; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
297 studies that test it; most in 2016 (22)
| Year | Studies |
|---|---|
| 1992 | 1 |
| 1993 | 1 |
| 1994 | 3 |
| 1995 | 6 |
| 1996 | 11 |
| 1997 | 10 |
| 1998 | 10 |
| 1999 | 21 |
| 2000 | 19 |
| 2001 | 18 |
| 2002 | 9 |
| 2003 | 9 |
| 2004 | 15 |
| 2005 | 12 |
| 2006 | 9 |
| 2007 | 10 |
| 2008 | 3 |
| 2009 | 7 |
| 2010 | 13 |
| 2011 | 7 |
| 2012 | 8 |
| 2013 | 11 |
| 2014 | 11 |
| 2015 | 8 |
| 2016 | 22 |
| 2017 | 8 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 11 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 33 · Other 271
Children's Oncology Group (30) · National Cancer Institute (NCI) (14) · M.D. Anderson Cancer Center (14) · Alliance for Clinical Trials in Oncology (11) · St. Jude Children's Research Hospital (10) · Fred Hutchinson Cancer Center (10) · Masonic Cancer Center, University of Minnesota (9) · University of Washington (9)
Often tested with
Tested in the same studies.
Cyclophosphamide (77) · Etoposide (50) · Vincristine (34) · Fludarabine (30) · Doxorubicin (27) · Cytarabine (27) · Carboplatin (24) · Melphalan (22)
Related medicines
As reviewed, each with the page that says it.
- A recombinant medicine of Granulocyte Colony-Stimulating Factor source
- One of Recombinant Granulocyte Colony-Stimulating Factor source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 6, 1 in phase 3
Studies that test Filgrastim, phase 3 first.
- Jun 2027Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell LymphomaPhase 3 · National Cancer Institute (NCI)
- Feb 2027CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaPhase 1 · Fred Hutchinson Cancer Center
- Mar 2027A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaPhase 1 · National Cancer Institute (NCI)
- Apr 2027A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy VolunteersPhase 1 · BioGeneric Pharma
- Jun 2027Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet DisorderPhase 1 · M.D. Anderson Cancer Center
- Sep 2027Stem Cell Transplantation in Crohn's DiseasePhase 1/2 · Cedars-Sinai Medical Center
Studies
Open first, then newest update. How each study uses Filgrastim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 304
- Stem Cell Mobilization and Apheresis for Life-threatening Blood DisordersRecruitingPhase 1St. Jude Children's Research HospitalNCT07585136Written as Filgrastim
- Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell DiseaseRecruitingPhase 2St. Jude Children's Research HospitalNCT07616154Written as Filgrastim
- Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine ModelsRecruitingPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT02015013Written as Filgrastim
- Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous DiseaseRecruitingPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT06325709Written as Filgrastim
- Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric GliomaNot yet recruitingPhase 2St. Jude Children's Research HospitalNCT07916389Written as Filgrastim
- Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIMEnrolling by invitationPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT07775313Written as Filgrastim
- A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaRecruitingPhase 1National Cancer Institute (NCI)NCT07012044Written as Filgrastim
- A Study to Compare the Pharmacokinetics, Pharmacodynamics, Immunogenicity, Safety and Tolerability of Filgrastim Biosimilar and Neupogen Reference Product in Healthy VolunteersNot yet recruitingPhase 1BioGeneric PharmaNCT07877467Written as Neupogen (filgrastim)
- Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket TrialRecruitingPhase 2Assistance Publique - Hôpitaux de ParisNCT06381661Written as G-CSF filgrastim
- Base-Edited Hematopoietic Stem/Progenitor Cell X-Linked Severe Combined Immunodeficiency Gene TherapyEnrolling by invitationPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT06851767Written as Filgrastim
- Study of G-CSF for DOR in Patients Undergoing IVFRecruitingPhase 4Center for Human ReproductionNCT07871825Written as Neupogen 300 μg subcutaneous injection
- Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromeRecruitingPhase 2M.D. Anderson Cancer CenterNCT00801489Written as Filgrastim-sndz
- Improving White Blood Cell Collection From Healthy DonorsRecruitingPhase 4National Institutes of Health Clinical Center (CC)NCT01553214Written as Filgrastim
- CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic LeukemiaRecruitingPhase 1Fred Hutchinson Cancer CenterNCT04375631Written as Filgrastim
- Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed MedulloblastomaRecruitingPhase 2St. Jude Children's Research HospitalNCT05535166Written as Filgrastim
- Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursRecruitingPhase 3University of SydneyNCT02582697Written as Filgrastim
- CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and LymphomaRecruitingPhase 1St. Jude Children's Research HospitalNCT07257419Written as Filgrastim
- Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic DonorsRecruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT07692841Written as Single-dose Granulocyte colony-stimulating factor (G-CSF)
- Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of Dose-dense Adriamycin-cyclophosphamide and Paclitaxel ChemotherapyRecruitingPhase 4Ottawa Hospital Research InstituteNCT05753618Written as Omission of Granulocyte Colony-Stimulating Factor (G-CSF)
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromeRecruitingPhase 2M.D. Anderson Cancer CenterNCT01624805Written as Filgrastim
See all 304 studies that test Filgrastim →
Given beside what is tested · 322 — Filgrastim is usual care or a partner of the new treatment
- Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk DiseaseRecruitingPhase 2St. Jude Children's Research HospitalNCT06023641Written as Filgrastim, peg-filgrastim
- The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell TransplantationRecruitingPhase 1/2National Cancer Institute (NCI)NCT05436418Written as Filgrastim
- Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic MalignanciesRecruitingPhase 1/2National Cancer Institute (NCI)NCT04959175Written as Filgrastim
- Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell LymphomasRecruitingPhase 1City of Hope Medical CenterNCT07278856Written as Filgrastim
- Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal AdenocarcinomaNot yet recruitingPhase 2Abramson Cancer Center at Penn MedicineNCT07059611Written as Filgrastim
- Phase 1/2 FLAG-IDA, VEN and Asciminib in CML and Ph+ AMLNot yet recruitingPhase 1/2M.D. Anderson Cancer CenterNCT07604233Written as Filgrastim
- Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid LeukemiaRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT03214562Written as Filgrastim
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingEarly Phase 1C17 CouncilNCT06942039Written as Filgrastim
- Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker DeclineRecruitingPhase 2Blokhin's Russian Cancer Research CenterNCT07847190Written as G-CSF (Filgrastim)
- Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal TumorsNot yet recruitingPhase 2Joal BeaneNCT07647068Written as Filgrastim
- A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTRecruitingPhase 2Children's Oncology GroupNCT04684368Written as Filgrastim
- A-TANGO Phase 2 StudyRecruitingPhase 2Yaqrit LtdNCT06890039Written as G-CSF (Filgrastim)
- hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)RecruitingPhase 2Leland MethenyNCT05052957Written as Filgrastim
- Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/LymphomaRecruitingPhase 2University of WashingtonNCT07224100Written as Filgrastim
- Allogeneic ORCA-Q Stem Cell Transplant for the Treatment of Relapsed and Refractory High Risk Multiple MyelomaNot yet recruitingPhase 1University of California, DavisNCT07759102Written as Filgrastim
- Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced MalignanciesRecruitingPhase 1/2University of California, IrvineNCT07064018Written as Filgrastim
- Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell TransplantRecruitingPhase 1/2M.D. Anderson Cancer CenterNCT04022239Written as Filgrastim-sndz
- Brentuximab Vedotin in Early Stage Hodgkin LymphomaRecruitingPhase 3University College, LondonNCT04685616Written as Haematopoietic growth factor
- MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.RecruitingPhase 2Masonic Cancer Center, University of MinnesotaNCT06412497Written as Post-Transplant G-CSF
- TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic MalignanciesRecruitingPhase 1St. Jude Children's Research HospitalNCT07052370Written as Filgrastim
Showing 20 of 322.
As the comparator · 24 — what is tested is compared with Filgrastim
- Telpegfilgrastim vs Filgrastim for Secondary Prevention of Chemotherapy-Induced Neutropenia in Pediatric Solid TumorsRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06926751Written as filgrastim
- Lapelga vs GastrofilNot yet recruitingPhase 3London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sNCT06116734Written as Grastofil®
- Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant FailureActive, not recruitingPhase 2National Heart, Lung, and Blood Institute (NHLBI)NCT02105766Written as Filgrastim
- Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ FunctionActive, not recruitingPhase 1/2National Heart, Lung, and Blood Institute (NHLBI)NCT06145282Written as Filgrastim
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell DiseaseActive, not recruitingPhase 1/2National Heart, Lung, and Blood Institute (NHLBI)NCT03077542Written as Filgrastim
- Study to Compare the Efficacy and Safety of F-627 and GRAN®CompletedPhase 3EVIVE BiotechnologyNCT04174599Written as GRAN®
- A Study of KRN125 in Patients With Multiple Myeloma and Malignant LymphomaCompletedPhase 2Kyowa Kirin Co., Ltd.NCT05007652Written as KRN8601(filgrastim), PLR001(plerixafor)
- Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AMLTerminatedPhase 3Cornerstone PharmaceuticalsNCT03504410Written as Fludarabine, Cytarabine, Filgrastim
- Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD ProphylaxisCompletedPhase 2Virginia Commonwealth UniversityNCT02593123Written as Filgrastim
- Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed NeulastaCompletedPhase 1Mylan Inc.NCT02479646Written as EU-Neulasta
- Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial CancerCompletedPhase 3GOG FoundationNCT00063999Written as Filgrastim
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer PatientsCompletedPhase 3Dong-A ST Co., Ltd.NCT03343145Written as Neupogen 5µg/kg/day
- Lymphocyte Reconstitution After Administration of Pegfilgrastim Versus Filgrastim After Peripheral Stem Cell TransplantationTerminatedNot applicableCentre Leon BerardNCT01541072Written as Filgrastim
- Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid TumorsWithdrawnPhase 2Teva Branded Pharmaceutical Products R&D, Inc.NCT01940601Written as Filgrastim
- Safety and Efficacy Study of Peripheral Blood Mononucleated Cells for Treatment of Liver CirrhosisCompletedPhase 1Seoul National University HospitalNCT01503749Written as G-colony stimulating factor
- Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating DA-3031 (PEG-G-CSF) to Filgrastim (Dong-A) in Healthy VolunteersCompletedPhase 1Dong-A ST Co., Ltd.NCT00959777Written as Filgrastim
- NOX-A12 Multiple Ascending Dose Study in Healthy VolunteersCompletedPhase 1TME Pharma AGNCT01194934Written as Filgrastim
- Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast CancerCompletedPhase 3European Organisation for Research and Treatment of Cancer - EORTCNCT00017095Written as filgrastim
- Pegfilgrastim Versus Filgrastim After High-dose ChemotherapyCompletedPhase 2Armando Santoro, MDNCT00410696Written as Filgrastim
- Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)WithdrawnPhase 2National Institute of Allergy and Infectious Diseases (NIAID)NCT00230035Written as Growth colony stimulating factor (G-CSF)
Showing 20 of 24.
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered1
- Molecularly Stratified Trial for Newly Diagnosed Infant-Type Hemispheric GliomaNov 4, 2026NCT07916389
Codes
What other systems call Filgrastim · ClinicalTrials.gg INT006616
- MeSH (NLM) D000069585FilgrastimConfirmed NLM, Wikidata
- UNII (FDA) PVI5M0M1GWFILGRASTIMConfirmed FDA, NLM, Wikidata
- RxNorm 68442Confirmed FDA, Wikidata
- Wikidata Q3151081filgrastimConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1474FilgrastimOne source FDA
- DrugBank DB00099One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069585 | Filgrastim | Confirmed NLM, Wikidata |
| UNII (FDA) | PVI5M0M1GW | FILGRASTIM | Confirmed FDA, NLM, Wikidata |
| RxNorm | 68442 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3151081 | filgrastim | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1474 | Filgrastim | One source FDA |
| DrugBank | DB00099 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.